Tesamorelin is a synthetic peptide that functions as an analog of growth hormone-releasing hormone (GHRH), primarily used to stimulate the body’s natural production of growth hormone. It was initially developed to address excess abdominal fat in individuals with HIV-related lipodystrophy, but its mechanism of action also makes it useful for improving body composition and metabolic function. By increasing endogenous growth hormone levels, Tesamorelin can support fat metabolism, promote lean muscle growth, and aid in tissue repair, making it a potential option for anti-aging and wellness-focused applications.

​

Tesamorelin binds to GHRH receptors in the pituitary gland, prompting the release of growth hormone into circulation. This increase in growth hormone leads to higher levels of insulin-like growth factor 1 (IGF-1), which is essential for cellular growth, protein synthesis, and fat utilization. Unlike direct growth hormone administration, Tesamorelin encourages a more natural hormonal response, helping to maintain physiological balance and reduce the risk of excessive dosing. These combined effects contribute to improved metabolic health, reduced visceral fat, and enhanced physical performance and recovery.